Vol 2, No 2 (2014)

Articles

Investigation of morphology and porous structure of medical clays

Zhilyakova E.T., Bondarev A.V.

Abstract

The article presents the results of the research of morphology and porous structure of medical clays. The specific surface area, volume of pores and the average size of pores were identified.
Pharmacy & Pharmacology. 2014;2(2):3-5
pages 3-5 views

INVESTIGATION OF PHYSICAL AND CHEMICAL PROPERTIES OF MEDICAL CLAYS FOR COSMETICS

Bondarev A.V., Zhilyakova E.T.

Abstract

The article presents the results of the research of the physical and chemical properties of medical clays. The form and size of particles, elemental composition are studied.
Pharmacy & Pharmacology. 2014;2(2):6-9
pages 6-9 views

RESEARCH OF THE PREPARATION «AMINALON-FARMAK» ON THE PHARMACEUTICAL MARKET OF THE UKRAINE: INFORMATION REVIEW

Kuchmistov V.A., Kuchmistova E.F.

Abstract

Among the contemporary medicinal remedies the derivatives of g - aminobutyric acid have a special place. The present work is devoted to the remedy «Aminalon» which has a dignity of a combination of nootropic and neuroprotective actions and it has special value for the geriatric and pediatric practices. The task of the authors was a holding of a market review with the purpose to generalize the information about the place of the given remedy as a segment of the pharmaceutical market.
Pharmacy & Pharmacology. 2014;2(2):10-18
pages 10-18 views

ADAPTING OF THE MILITARY PHARMACEUTISTS TO LABOUR ACTIVITY

Khomutetskaya N.I., Golub A.G.

Abstract

The article is devoted to problems of the military pharmaceutists labour adapting. The probable approaches of problem solution of preparation of the students to next independent activity are considered.
Pharmacy & Pharmacology. 2014;2(2):19-22
pages 19-22 views

SESQUITERPENE LACTONES OF LEAVES AND FRUITS OF LAURUS NOBILIS L

Konovalov D.A., Nasuhova N.M.

Abstract

Bay laurel (Laurus nobilis L.) is common in the Mediterranean region, Europe and America. Widely cultivated in the countries of the Arabian Peninsula and North Africa. As the basic active substances in plants: essential oil components, sesquiterpene lactones, alkaloids, and phenolic compounds (flavonoids, phenolic acids and lignans) are described. In the plant more than 30 sesquiterpene lactones are found. Structural types of these compounds include eudesmanolides, germacranolides, guaianolides. Sesquiterpene lactones isolated from the leaves and fruits of Laurus nobilis, possess antibacterial, antifungal, anti-diabetic, anti-inflammatory, hepatoprotective, neuroprotective and cytotoxic activity. They inhibit the absorption of alcohol increases the activity of hepatic glutathione-S-transferase. Most of these types of activity of sesquiterpene lactones from laurel due to the presence within their structure of α-methylene-g-butyrolactone part. Thus, sesquiterpene lactones-containing leaves and fruits Laurus nobilis could have been an important source of raw materials for the creation of new medicines.
Pharmacy & Pharmacology. 2014;2(2):23-33
pages 23-33 views

POLYACETYLENE COMPOUNDS IN SPECIES OF GENUS BIDENS

Konovalov D.A., Nasukhova A.M.

Abstract

In genus Bidens, as well as in family Asteraceae as a whole, different researchers had described polyacetylenes, sesquiterpene lactones and flavonoids. Interest to these classes of substances also has been caused by their antiparasitic, antifungal, antioxidant, cytotoxic and other properties. Within family Asteraceae polyacetylenes are widespread in tribe Heliantheae and genus Bidens . They are capable to be accumulated in all parts of plants of this genus though they have been most often found out in roots. In species of genus Bidens the most widespread are С 17-, С 14-, С 13-polyacetylenes, and also aromatic derivatives and thiophenes. Other group of the polyacetylenes found out in species of the genus - polyacetylene glucosides. According to the majority of researchers of this group of polyacetylenes, the glycosidation is a way facilitating of transportation of typically lipophilic compounds. The majority of these polyacetylenes is revealed in species of genus Bidens.
Pharmacy & Pharmacology. 2014;2(2):34-65
pages 34-65 views

STUDY OF COORDINATION OF IMMUNOACTIVE PEPTIDES WITH METAL IONS AS A BASIS FOR THE DEVELOPMENT OF INNOVATIVE DRUGS

Bunyatyan N.D., Bobiev G.M.

Abstract

The results of development of the immunomodulator timotsin based on coordination compounds dipeptide isoleucyl-tryptophan with zinc, including the synthesis of low molecular weight peptides by immunoactive activated esters, determination regarding the immunostimulatory activity of thymosin α1, study of coordination of dipeptide isoleucyl-tryptophan with zinc, study the immunostimulatory activity of coordination compounds, the results of preclinical and clinical studies of timotsin. pH-metric method and red-ox titration showed that the interaction of zinc and of dipeptide isoleucyl-tryptophan formed in solution following complex forms: [ZnHL] (lgæ = 3,71), Zn(HL) 2 (lgβ = 0,279), ZnL(HL) (lgβ = 6,6), Zn 2(HL) 2 (lgβ = 188), Zn(OH)(HL) (lgβ = -0,256). It was shown that the immunostimulatory activity of coordination compounds is in 2-8 times greater than the starting dipeptide. The developed immunomodulatory drug timotsin showed high therapeutic efficacy in the treatment of viral hepatitis, malignant tumors of different localization, psoriasis and neurodermatitis. Timotsin is registered in Tajikistan (registration number of medical drug №000085T), Kyrgyzstan (medical drug №7137) and Turkmenistan (registration number 006371).
Pharmacy & Pharmacology. 2014;2(2):66-75
pages 66-75 views

ANTIBACTERIAL ACTIVITY OF BENZIMIDAZOLES 2-THIO, 2-AMINODERIVATIVES AND COMPLEXES OF BENZIMIDAZOLES WITH TRANSITIONAL METALS

Mayboroda E.I., Britsun V.N.

Abstract

The literature data about antibacterial properties of benzimidazole 2-thio-, 2-aminoderivatives and benzimidazole complexes have been generalized and systematized in the review. Today prevention and treatment of diseases caused by microorganisms is an actual problem of modern therapy. Therefore, the search for active molecules, the based on them development of some new, more effective antimicrobial agents is an important task of modern pharmaceutical chemistry. Promising compounds for solving these problems are benzimidazole derivatives. They are available, functionally capable, stable and have a wide spectrum of biological activities (antiviral, anthelmintic, antibacterial, anticancer, antidiabetic). The purpose of this paper is to generalize and systematize information about the antimicrobial action of 2-thio-, 2-amino-substituted benzimidazoles and benzimidazole derivatives complexes with transition metals. These compounds and their complexes with transition metals are active against pathogenic strains Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Proteus vulgaris, Bacillus cereus, Micrococcus luteus , Helicobacter рylori and others.
Pharmacy & Pharmacology. 2014;2(2):76-87
pages 76-87 views

DEVELOPMENT OF A NEW IMMUNOMODULATING DRUG TIMOFER

Kholnazarov B.M., Bobiev G.M., Bunyatyan N.D.

Abstract

Results of the development of an immunomodulating drug timofer based on coordination compounds isoleucyl-tryptophan dipeptide with iron (II), including the study of coordinate isoleucyl-tryptophan dipeptide with iron (II), the study of the immunostimulatory activity of the coordination compounds, the results of the preclinical and clinical studies of timotsin are presented. Method of pH titration showed that the interaction of zinc and dipeptide isoleucyl-tryptophan formed in solution following complex forms: [Fe (HL ±)] 2+ (β = 1,00×10 34), [Fe (HL ±) 2] 2+ (β = 6,25×10 11), [Fe (HL ±)OH] + (β = 4,01×10 26), [Fe (L -)] + (β = 8,10×10 18), [Fe (L -) 2] + (β = 7,50×10 28), [Fe (L -)OH] + (β = 1,03×10 29). It was shown that the immunostimulatory activity of the coordination compounds is 2 times higher than that starting dipeptide. The substance sample and standard formulation of timofer were developed and standardized. The developed immunomodulatory drug timofer showed a high therapeutic efficacy in the treatment of iron deficiency anemia patients with inflammatory processes and traumatic injuries of the maxillofacial region, with chronic inflammatory diseases of the the genitals (CMV, HSV, chlamydia, chronic endometritis, chronic salpingoopharitis, ureaplasmosis) with chronic bronchitis, chronic obstructive bronchitis, bronchial asthma, pneumonia, chronic glomerulonephritis, and chronic renal failure complicated by anemia Bright, withrheumatic diseases, gynecological patients with anemia of moderate and severe degrees of severity, at surgical treatment of patients with suppurative lung disease, heart disease and chronic pericarditis operated with cardiopulmonary bypass. Timofer is registered in Tajikistan (registration number of medical drug №002866).
Pharmacy & Pharmacology. 2014;2(2):88-97
pages 88-97 views

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».